Serum Hepcidin Predicts Uremic Accelerated Atherosclerosis in Chronic Hemodialysis Patients with Diabetic Nephropathy
Background: Hepcidin, as a regulator of body iron stores, has been recently discovered to play a critical role in the pathogenesis of anemia of chronic disease. Atherosclerotic cardiovascular disease is the most common complication and the leading cause of death in chronic hemodialysis (CHD) patient...
| Autors principals: | , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Wolters Kluwer
2015-01-01
|
| Col·lecció: | Chinese Medical Journal |
| Matèries: | |
| Accés en línia: | http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=10;spage=1351;epage=1357;aulast=Li |